Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Biora Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of BIOR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders5549−6
Shares51.0M49.3M−1.77M (−3.5%)
Value$59.2M$34.5M−$24.7M (−41.7%)

New holders (8)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to BIOR in Q2 2022
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC432,000$302.0K0.01%
Wolverine Trading, LLC48,116$33.0K0.00%
Principal Financial Group Inc18,600$13.0K0.00%
AdvisorNet Financial, Inc3,856$3.00K0.00%
UBS Group AG1,016$1.00K0.00%
Urban Wealth Management, LLC890$1.00K0.00%
Tucker Asset Management LLC500$3500.00%
Simplex Trading, LLC501$00.00%

Sold out (14)

Institutions that held Biora Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.